Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
P. P. Luxco Holdings II S.à r.l. is a Luxembourg-based holding company and a wholly-owned subsidiary of Picchio Pharma Inc., a healthcare-focused investment firm. The company served as a strategic investment vehicle for Picchio Pharma, which was a joint venture between Power Corporation of Canada and the prominent biotechnology entrepreneur Dr. Francesco Bellini. Its primary function was to manage equity stakes in life science companies, most notably Bellus Health (formerly Neurochem), which specialized in therapeutics for chronic cough and other conditions. Through its parent and affiliates, P. P. Luxco Holdings II was instrumental in the financing and development of several biotechnology and medical diagnostic firms before its primary assets were transitioned or acquired.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on P. P. Luxco Holdings II.